Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Desvenlafaxine in the Preventive Treatment of Frequent Migraines
NCT07385755Active, not recruiting
- Sponsor
- Tongji Hospital
- Start
- Jan 2026
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in migraine comparing Desvenlafaxine with Placebo (2 arms). Primary endpoint: Change from baseline in monthly migraine days at 12 weeks. Started Jan 2026; status: active, not recruiting.
02
Drugs
desvenlafaxine
03
Conditions
migraine
Beyond the preview
Go deeper on NCT07385755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07385755.